MALLINCKRODT PLC news, videos and press releases - Page 3
For more news please use our advanced search feature.
MALLINCKRODT PLC - More news...
MALLINCKRODT PLC - More news...
- Mallinckrodt plc Reports Earnings for the First Quarter 2020 and Highlights Pipeline Progress
- Mallinckrodt Announces Positive Findings in INOmax® (Nitric Oxide) Gas, for Inhalation Phase 4 Observational Registry in Neonates with Pulmonary Hypertension; Ends Trial Early
- Mallinckrodt Supports Investigator-Initiated Study at Massachusetts General Hospital to Assess Effectiveness of Inhaled Nitric Oxide in Patients with Severe Acute Respiratory Distress Syndrome Due to COVID-19
- Mallinckrodt Announces U.S. Food and Drug Administration (FDA) Filing Acceptance of New Drug Application for Terlipressin for Treatment of Hepatorenal Syndrome Type 1 (HRS-1)
- Mallinckrodt to Report Earnings Results for First Quarter 2020
- Mallinckrodt Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 04-10-2020
- Mallinckrodt Initiates Rolling Submission of Biologics License Application for StrataGraft® Regenerative Skin Tissue to U.S. Food and Drug Administration
- Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 03-24-2020
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 03-23-2020
- Mallinckrodt Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration (FDA) for Terlipressin for the Treatment of Patients with Hepatorenal Syndrome Type 1 (HRS-1)
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 03-16-2020
- Mallinckrodt Confirms Court Decision in Lawsuit Against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) and Provides Update Related to Global Opioid Settlement and Present Financing Activities
- Mallinckrodt Evaluates the Potential Role for Inhaled Nitric Oxide to Treat COVID-19 Associated Lung Complications, Engages with Scientific, Governmental and Regulatory Agencies
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 03-11-2020
- Mallinckrodt Provides Update on Proposed Global Opioid Settlement
- Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Immunoglobulin A Nephropathy (IgAN) Published in Kidney International Reports
- Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews
- Mallinckrodt Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration (FDA) for Terlipressin for the Treatment of Patients with Hepatorenal Syndrome Type 1 (HRS-1)
- Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020
- Mallinckrodt plc Reports Strong Fourth Quarter and 2019 Results
- Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 02-24-2020
- Jay Pharma Appoints Former Mallinckrodt plc Executive as Audit Committee Chair
- Mallinckrodt to Report Earnings Results for Fourth Quarter and Fiscal 2019
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 02-04-2020
- Mallinckrodt Recognized as one of the "2020 Best Places to Work for LGBTQ Equality"
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 01-22-2020
- Mallinckrodt plc - MNK Stock Chart Technical Analysis for 01-21-2020